Journal of Neuropathology & Experimental Neurology · 1998 · 82 citations · 14 references
Life SciencesNeurobiologyNeuroscienceCellular NeuroscienceNeurobiology Of DiseaseNeurodegenerationAlzheimer DiseaseApoptosis In NeurodegenerationNeurodegenerative DiseasesNeurodegenerative DisordersNeuroinflammationNeuropathology Of DementiaAlzheimer Disease ProgressionAmyloid Beta PlaquesAmyloid Plaque FormationAmyloid PlaquesAmyloid-beta-induced NeurotoxicityNeuritic PlaquesNeuronal DysfunctionNeuronal Injury Markers
Neuronal injury associated with amyloid plaque progression in Alzheimer disease was examined using TUNEL combined with beta-amyloid immunolabeling. There was a progressive increase in the frequency of TUNEL-positive neurons associated with plaque types representing a hypothesized sequence of plaque evolution, from 20% of neurons not associated with plaques to 40%, 70-80%, and 100% of neurons in diffuse, neuritic, and dense-core non-neuritic plaques, respectively. The total number of neurons associated with end-stage, dense-core, non-neuritic plaques declined by 70% (per unit plaque area) compared with neuritic plaque forms. This decline, together with the fact that virtually all of those remaining were TUNEL-positive, suggests that neuronal cell damage increases as plaques evolve from diffuse to more complex forms and that eventually all plaque-associated neurons are lost. This novel demonstration of neurotoxicity associated with amyloid plaque formation and progression suggests that plaque-associated neuronal injury is a major cause of neuronal loss in Alzheimer disease.
14
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Suzanne S. Mirra, Albert Heyman, Daniel W. McKeel et al. · Neurology · 1991 · 5.1K citations
Immunohistochemical evidence for apoptosis in Alzheimerʼs disease
Joseph H. Su, Alleen J. Anderson, B. Cummings et al. · Neuroreport · 1994 · 572 citations